TSH Biopharm Corp. Ltd.(TW:8432)
NT$61.90+0.40 (+0.65%)
TW:8432
TSH Biopharm Corp. Ltd. Revenue
NT$61.90
At close:+0.40 (+0.65%)
TSH Biopharm Corp. Ltd. (8432) Revenue
TSH Biopharm Corp. Ltd. Revenue
TSH Biopharm Corp. Ltd. had a revenue of 330.69M in the quarter ending Jun 30, 2026, with 15.70%. This bring the company's revenue in the last twelve months to 1.40B, Increased 4.60%. In the fiscal year ending Dec 31, 2025, TSH Biopharm Corp. Ltd. had annual revenue of 1.34B with 19.79% growth.
- Revenue (ttm)
- 1.40B
- Revenue Growth
- 20.56%
- P/S Ratio
- 1.77
- Revenue/Employee
- TWD 16,706,538
- Employees
- 80
- Market Cap
- TWD 2.36B
Revenue Chart
TSH Biopharm Corp. Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.34B | 220.81M | 19.79% |
| Dec 31, 2024 | 1.12B | 304.80M | 37.59% |
| Dec 31, 2023 | 810.92M | 69.85M | 9.43% |
| Dec 31, 2022 | 741.07M | 327.58M | 79.23% |
| Dec 31, 2021 | 413.48M | -34.38M | -7.68% |
| Dec 31, 2020 | 447.86M | -59.80M | -11.78% |
| Dec 31, 2019 | 507.67M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.